2 to 48 mg/m 2 bsa/day)
A 39‐year‐old woman was administrated methylprednisolone for newly diagnosed multiple sclerosis
Objective: To report a multicenter series of patients with MS who were treated at home for a relapse with a 3-day course of intravenous methylprednisolone
Steroids (also known as corticosteroids) may be used to treat relapses in multiple sclerosis
In treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of methylprednisolone for a week followed by 64 mg every other day for 1 month have been shown to be effective (see PRECAUTIONS, Neurologic-psychiatric)
N P Goldstein , W F McGuckin , B F McKenzie , V R Mattox
Methylprednisolone / administration & dosage
High-dose short-term methylprednisolone is the recommended treatment in the management of multiple sclerosis relapses, although it has been suggested that lower doses may be equally effective
2005 Mar 22;64 (6):1100; author reply 1100
The aim of this study was to evaluate the prevalence and severity of liver injury in patients with MS after pulsed methylprednisolone therapy
Our aim was to investigate differences in immune mechanisms in multiple sclerosis (MS) relapse, after high-dose oral methylprednisolone (oMP) or intravenous methylprednisolone (ivMP)
The Expanded Disability Status Scale, the timed 25-foot walk test and the nine-hole peg test were assessed in 112 multiple sclerosis patients before and 6 weeks after intravenous methylprednisolone
These findings suggest that we may be able to replace ivMP with oMP to treat MS relapses
Background: A short course of intravenous methylprednisolone (IVMP) followed by oral prednisone taper (OPT) is often used for the treatment of relapses in multiple sclerosis (MS)
Methods: I
, )